Topline data expected in 1Q 2028 Phase 2 bipolar depression trial initiation follows positive Phase 2 results in acute schizophrenia NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc ...
"Our year is off to a strong start and the initiation of this Phase 2 trial in patients with bipolar depression marks an ...
Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous ...
Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that it will ...
Johnson & Johnson (NYSE: JNJ) announced today that 11 abstracts featuring new data on its robust portfolio and pipeline in neuropsychiatry will be presented at the 64th Annual Meeting of the American ...
Anti-inflammatory treatment reduced depressive symptoms and anhedonia in patients with elevated inflammation. Learn more.
Naoise Mac Giollabhui, PhD, of the Department of Psychiatry at Mass General Brigham, is the lead author of a paper published in American Journal of Psychiatry, "Effect of anti-inflammatory treatment ...
BioMed X, a leading innovation hub in the US, has joined forces with AbbVie to launch a new research project aimed at understanding anhedonia – the persistent loss of the ability to feel pleasure. The ...
Feeling underwhelmed by life could mean you’re experiencing anhedonia, but all is not lost ...
Almost 20% of youth in the United States experience their first major depressive episode between the ages of 10–19 (Bitsko, 2022), making major depressive disorder (MDD) one of the most prevalent ...